Selinexor in Combination With MTX+Ritu to Treat R/R CNSL
Condition: Central Nervous System Lymphoma Interventions: Drug: Selinexor; Drug: Rituximab; Drug: Methotrexate Sponsors: Tong Chen; Antengene Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials